AGE - Functional Reserve
AGE-FR
Renal Hemodynamic, Functional and Metabolic Changes After AGEs (Advanced Glycation End Products) Load by Positron Emission Tomography (PET) and Blood Oxygen Level-Dependent (BOLD) - MRI. The AGE- Functional Reserve Study.
1 other identifier
interventional
10
1 country
1
Brief Summary
Renal functional reserve is defined as the glomerular hyper filtration induced by a protein load. Renal blood flow and Glomerular Filtration Rate (GFR) increase in response to a protein load. Renal functional reserve loss is associated with a persistent hyper filtration state, seen in first stages of diabetic nephropathy, leading to progression of Chronic Kidney Disease (CKD). This observation has lead to larger clinical studies that demonstrated the positive effects of protein restriction on kidney function, and allowed the scientific community to recommend low proteins diet (less than 0.8 g / kg/ day) to prevent CKD progression. Nevertheless, the precise mechanisms responsible for kidney hemodynamic and metabolic changes induced by a protein load, are debated. Uribarri et al have suggested that renal hemodynamic changes induced by a protein load are mainly due to the Advanced Glycation End Products (AGEs) content. Indeed, initial studies experimental conditions leading to the demonstration of renal functional reserve (amino acid or protein perfusion or cooked meat), were in fact responsible for an AGEs load, based on recent published data. The aim of this study is to determine whether AGEs alone or proteins in general are responsible for the mobilization of renal functional reserve, leading to the progression of CKD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2016
CompletedFirst Submitted
Initial submission to the registry
February 26, 2016
CompletedFirst Posted
Study publicly available on registry
March 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedSeptember 3, 2025
August 1, 2025
5 months
February 26, 2016
August 26, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Renal Blood Flow
Differences in Renal blood flow will be assessed 120 minutes after 2 different meals, either high AGE (mixed nuggets) or low AGE meal (mixed eggs), with PET- MRI using 150 labeled water.
120 minutes after meal
Secondary Outcomes (2)
renal oxygen content
120 minutes after meal
renal oxidative metabolism
120 minutes after meal
Study Arms (2)
Low AGE meal
EXPERIMENTALRenal functional parameters are measured at baseline and after a low AGE (eggs) meal
High AGE meal
EXPERIMENTALRenal functional parameters are measured at baseline and after a high (mixed nuggets) AGE (eggs) meal
Interventions
Eligibility Criteria
You may qualify if:
- Healthy males subjects
- age between 18 and 30 years old
You may not qualify if:
- Kidney disease
- Diabetes
- Obesity
- Hypertension
- Non Steroidal Anti Inflammatory Drug treatment (NSAIDS)
- MRI Contra indications
- Myeloma
- High basal Radiation exposure : more than 1 milliSievert (mSv) in the last 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Néphrologie - Hôpital Edouard Herriot
Lyon, 69437, France
Related Publications (1)
Normand G, Lemoine S, Villien M, Le Bars D, Merida I, Irace Z, Troalen T, Costes N, Juillard L. AGE Content of a Protein Load Is Responsible for Renal Performances: A Pilot Study. Diabetes Care. 2018 Jun;41(6):1292-1294. doi: 10.2337/dc18-0131. Epub 2018 Apr 2.
PMID: 29610272BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Laurent JUILLARD, MD, PhD
Hospices Civils de Lyon
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2016
First Posted
March 1, 2016
Study Start
February 1, 2016
Primary Completion
July 1, 2016
Study Completion
July 1, 2016
Last Updated
September 3, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share